Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Delek US Holdings, Inc.    DK   US2466471016

Delayed Quote. Delayed Nyse - 05/26 04:01:16 pm
36.66 USD   -2.63%
05/21 DELEK US HOLDIN : ex-dividend day
05/14 DELEK US : Completes the Acquisition of 48 Percent Ownership Interes..
05/12 DELEK US : Announces Investor Conference Schedule
Analysis summary4-Traders Strategies 

Delek US Holdings, Inc. : Still an upward potential

02/12/2013 | 09:07am
Opinion : Bullish above USD 36
Target price : USD 43
Stop loss: USD 34.2
Oil & Gas Refining and Marketing

Delek US Holdings continues its bullish trend in order to test new highest level.

The company’s fundamentals are still strong. Sales are up 9.9% for one year. Analysts from Thomson Reuters consensus have revised largely upward their EPS estimates.

Technically, the security is in an uptrend on all time scales and it is supported by moving averages. The bullish trend will not be stopped until prices are above the USD 30.2 short term support. This trend should allow the stock to reach its USD 43 resistance.

In consequence, investors can take a long position in Delek US Holdings with a first target price at USD 43. A new bullish fluctuation could lead the security toward its highest level in case of breakout of this resistance. A stop loss will be fixed below the pivot point.

Delek US Holdings, Inc. : Delek US Holdings, Inc. : Still an upward potential

© 2013

Disclaimer: is a website published by SURPERFORMANCE SAS. Surperformance or is not a registered broker-dealer nor a registered investment adviser. You understand that this web site and its content is furnished for your personal, noncommercial, informational purposes only, and that no mention of a particular security in this website constitutes a recommendation to buy, sell, or hold any other security, nor that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Surperformance and services will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. Information regarding trading and investment as provided by Surperformance professional is not tailored to the investment needs of any specific person. You acknowledge that you are responsible for your own financial decisions and should seek a registered financial agent depending on your own risk tolerance to advise you on your personal trading activities.

Financial Ratios

Size 2015e 2016e
Capitalization 2 160 M$ -
Entreprise Value (EV) 2 487 M$ 2 438 M$
Valuation 2015e 2016e
PER (Price / EPS) 14,6x 12,1x
Capitalization / Revenue 0,37x 0,31x
EV / Revenue 0,42x 0,34x
EV / EBITDA 5,38x 4,84x
Yield (DPS / Price) 1,98% 2,24%
Price to book (Price / BVPS) 1,61x 1,41x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 5,88% 5,67%
operating Leverage (Delta EBIT / Delta Sales) -0,19x 0,79x
Net Margin (Net Profit / Revenue) 2,86% 2,88%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 15,2% 14,1%
Rate of Dividend 28,8% 27,1%
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   4,07% 2,93%
Cash Flow / Sales (Taux d'autofinancement) 5,48% 4,66%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) 0,71x 0,55x
Income Statement Evolution
More Financials
EPS Revisions